Effects of C-peptide on Blood Flow in Diabetes
Author Information
Author(s): T. Forst, T. Kunt
Primary Institution: Institute for Clinical Research and Development, Mainz, Germany
Hypothesis
C-peptide supplementation may improve microvascular blood flow and erythrocyte deformability in type 1 diabetic patients.
Conclusion
C-peptide improves microvascular function and blood flow in type 1 diabetic patients by enhancing erythrocyte deformability and vascular regulation.
Supporting Evidence
- C-peptide administration improved erythrocyte Na+K+ATPase activity by about 100%.
- C-peptide supplementation increased nutritive capillary blood flow in type 1 diabetic patients.
- Statistical analysis showed significant improvements in blood flow and erythrocyte deformability after C-peptide administration.
- C-peptide enhanced nitric oxide release from endothelial cells, contributing to vasodilation.
- Impaired Na+K+ATPase activity in diabetes was restored by C-peptide, improving blood flow.
- C-peptide's effects on blood flow were observed in both in vitro and in vivo studies.
- Type 1 diabetic patients showed a significant increase in capillary blood flow after C-peptide infusion.
- C-peptide's effects were not observed in healthy controls, indicating its specific action in diabetic patients.
Takeaway
C-peptide helps blood flow in people with type 1 diabetes by making their blood cells more flexible and improving how their blood vessels work.
Methodology
The study involved in vitro and in vivo investigations assessing the effects of C-peptide on endothelial function, erythrocyte deformability, and microvascular blood flow in type 1 diabetic patients.
Potential Biases
Potential bias due to the study's focus on specific patient demographics and the reliance on certain methodologies.
Limitations
The study primarily focused on type 1 diabetes and may not be generalizable to other forms of diabetes.
Participant Demographics
Type 1 diabetic patients and healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website